Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Vaxart, Inc. | d10k.htm |
| EX-32 - SECTION 1350 CERTIFICATION - Vaxart, Inc. | dex32.htm |
| EX-31.1 - RULE 13A-14(A)/ 15D-14(A) CERTIFICATION - Vaxart, Inc. | dex311.htm |
Exhibit 23
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
Registration Statements (Forms S-8 No. 333-115691, No. 333-115688, No. 333-109017, No. 333-38864, No. 333-38868, No. 333-95269, No. 333-56037, No. 333-56071, No. 033-65069, No. 033-60795, No. 333-134954, No. 333-143238 and No. 333-143239) pertaining to various employee-related plans of Nabi Biopharmaceuticals;
of our reports dated March 10, 2010, with respect to the consolidated financial statements and schedule of Nabi Biopharmaceuticals and the effectiveness of internal control over financial reporting of Nabi Biopharmaceuticals, included in this Annual Report (Form 10-K) for the year ended December 26, 2009.
/s/ Ernst & Young LLP
McLean, Virginia
March 10, 2010